Stephen S. Tang
Net Worth
Last updated:
What is Stephen S. Tang net worth?
The estimated net worth of Dr. Stephen S. Tang is at least $15,295,888 as of 14 May 2019. He owns shares worth $335,888 as insider and has received compensation worth at least $14,960,000 in OraSure Technologies, Inc..
What is the salary of Stephen S. Tang?
Dr. Stephen S. Tang salary is $1,870,000 per year as Pres, Chief Executive Officer & Director in OraSure Technologies, Inc..
How old is Stephen S. Tang?
Dr. Stephen S. Tang is 64 years old, born in 1961.
What stocks does Stephen S. Tang currently own?
As insider, Dr. Stephen S. Tang owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
OraSure Technologies, Inc. (OSUR) | Pres, Chief Executive Officer & Director | 119,960 | $2.8 | $335,888 |
What does OraSure Technologies, Inc. do?
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
Stephen S. Tang insider trading
OraSure Technologies, Inc.
Dr. Stephen S. Tang has made 6 insider trades between 2017-2019, according to the Form 4 filled with the SEC. Most recently he purchased 1,000 units of OSUR stock on 14 May 2019.
The largest trade he's ever made was exercising 40,000 units of OSUR stock on 15 Feb 2017. As of 14 May 2019 he still owns at least 119,960 units of OSUR stock.
OraSure Technologies key executives
OraSure Technologies, Inc. executives and other stock owners filed with the SEC:
- Dr. Stephen S. Tang (64) Pres, Chief Executive Officer & Director
- Ms. Kathleen Gallagher Weber (58) Executive Vice President & Bus. Unit Leader of Molecular Solutions
- Ms. Lisa Nibauer (57) Executive Vice President & Bus. Unit Leader of Diagnostics